Login to Your Account

Part I: Late-Stage Research

Detecting and Preventing AD Focus of Products in Pipeline

By Peter Winter

Monday, October 21, 2013

One of the burning topics that industry and academic scientists, policymakers and patients will be discussing this week at a one-day forum focused on the primary hurdles to combating Alzheimer’s disease (AD), sponsored by the Pharmaceutical Research and Manufacturers of America, the Alzheimer’s Association and the Alzheimer’s Drug Discovery Foundation, will be how to accelerate the impact of pre-competitive collaborative partnerships to get products moving into clinical trials.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription